Recombinant Human Granulocyte Colony-Stimulating Factor Injection

Ncpc genetech biotechnology co.,ltd offers a wide range of products which includes recombinant human granulocyte colony-stimulating factor injection. Feature: it is mainly to promote the growth of neutral cells for various reasons caused by (such as cancer radiotherapy and chemotherapy, aids, anemia), enhance immune function. Phase ii clinical trial results show that: gisai xin can significantly reduce the chemotherapy-induced reduction of wbc and anc, shorten the duration of wbc and anc down to below normal, and promote the reduction of wbc and anc early recovery, to help chemotherapy on schedule and mild adverse reactions. Contact us for more information.